Modeling and resistant alleles explain the selectivity of antimalarial compound 49c towards apicomplexan aspartyl proteases
Published inEMBO Journal, e98047
Publication date2018
Research groups
Funding
- Autre - Carigest
- Swiss National Science Foundation - Non-Haemoglobin Degrading Plasmepsins: Drug Targets validation from Bench to Field [IZLIZ3_156825]
- Swiss National Science Foundation - FN3100A0-116722 and IZLIZ3- 156825
Citation (ISO format)
MUKHERJEE, Budhaditya et al. Modeling and resistant alleles explain the selectivity of antimalarial compound 49c towards apicomplexan aspartyl proteases. In: EMBO Journal, 2018, p. e98047. doi: 10.15252/embj.201798047
Main files (1)
Article (Published version)
Identifiers
- PID : unige:103072
- DOI : 10.15252/embj.201798047
- PMID : 29519896
ISSN of the journal0261-4189